Drug addiction places tremendous social, medical and economic burdens on society. Recent developments in this area have contributed to the notion that drug abuse is a problem with definable biological underpinnings. Despite this progress, the molecular organizing principles responsible for susceptibility to the initiation and maintenance of drug taking behavior have remained elusive. Modalities for therapeutic management of the condition are also lacking. In this application, we propose to use novel and complementary approaches to identify molecular factors that underlie drug seeking behaviors. We will take advantage of several recently established lines of mice in which different genes involved in monoaminergic neurotransmission have been inactivated. The different lines all show a sensitization to the locomotor enhancing effects of psychostimulants that is similar to that seen after chronic drug treatment. We will use a genome- wide mutational approach (ENU mutagenesis) to screen for second site mutations that modify the phenotype of existing knockout mutations. This approach has been pioneered in other genetic systems where it has proven to be a uniquely powerful tool. We will also characterize mutant mice using neurochemical and biochemical approaches and High Density Oligonucleotide Array technology to characterize gene expression profiles in the central nervous system. This should allow identification of genes involved in stable alterations of the CNS associated with chronic drug exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA013511-01
Application #
6198086
Study Section
Special Emphasis Panel (ZDA1-RXL-E (03))
Program Officer
Satterlee, John S
Project Start
2000-05-15
Project End
2005-04-30
Budget Start
2000-05-15
Budget End
2001-04-30
Support Year
1
Fiscal Year
2000
Total Cost
$367,781
Indirect Cost
Name
Duke University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Berlanga, M L; Price, D L; Phung, B S et al. (2011) Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons. Brain Res 1390:41-9
Ramsey, Amy J; Milenkovic, Marija; Oliveira, Ana F et al. (2011) Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci U S A 108:5795-800
Beaulieu, Jean-Martin; Gainetdinov, Raul R; Caron, Marc G (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327-47
Thanos, Panayotis K; Michaelides, Michael; Benveniste, Helene et al. (2008) The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse 62:319-24
Beaulieu, Jean-Martin; Caron, Marc G (2008) Looking at lithium: molecular moods and complex behaviour. Mol Interv 8:230-41
Beaulieu, Jean-Martin; Gainetdinov, Raul R; Caron, Marc G (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166-72
Salahpour, Ali; Medvedev, Ivan O; Beaulieu, Jean-Martin et al. (2007) Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 61:65-9
Beaulieu, Jean-Martin; Sotnikova, Tatyana D; Gainetdinov, Raul R et al. (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J Biol Chem 281:32072-80
Torres, Gonzalo E; Caron, Marc G (2005) Approaches to identify monoamine transporter interacting proteins. J Neurosci Methods 143:63-8
Medvedev, Ivan O; Gainetdinov, Raul R; Sotnikova, Tatyana D et al. (2005) Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. Psychopharmacology (Berl) 180:408-13

Showing the most recent 10 out of 15 publications